D.A. Davidson & Co. Pfizer Inc Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Pfizer Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 1,571,090 shares of PFE stock, worth $46.7 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

1,571,090

Previous 1,162,856 35.11%

Holding current value

$46.7 Million

Previous $32.3 Million 36.23%

% of portfolio

0.39%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $10.3 Million - $12.1 Million	408,234 Added 35.11%	1,571,090 $44 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $13.2 Million - $15.1 Million	508,108 Added 77.6%	1,162,856 $32.3 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $2.15 Million - $2.8 Million	-82,381 Reduced 11.18%	654,748 $18.9 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $730,913 - $854,365	22,777 Added 3.19%	737,129 $24.5 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $1.45 Million - $1.67 Million	40,015 Added 5.93%	714,352 $26.2 Million
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $2.44 Million - $3.18 Million	-61,971 Reduced 8.42%	674,337 $27.5 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $569,136 - $742,944	13,632 Added 1.89%	736,308 $37.7 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $738,099 - $901,035	16,867 Added 2.39%	722,676 $31.6 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $903,891 - $1.07 Million	19,426 Added 2.83%	705,809 $37 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $490,074 - $607,263	10,712 Added 1.59%	686,383 $35.5 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $111,564 - $165,375	2,700 Added 0.4%	675,671 $39.9 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $176,664 - $226,940	4,501 Added 0.67%	672,971 $28.9 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $527,625 - $597,711	14,693 Added 2.25%	668,470 $26.2 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $6.12 Million - $6.9 Million	182,725 Added 38.79%	653,777 $23.7 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $1.29 Million - $1.64 Million	38,443 Added 8.89%	471,052 $17.3 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $1.84 Million - $2.15 Million	57,840 Added 15.43%	432,609 $15.9 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $2.69 Million - $3.26 Million	-89,327 Reduced 19.25%	374,769 $12.3 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $913,668 - $1.31 Million	33,802 Added 7.86%	464,096 $15.1 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $1.56 Million - $1.77 Million	47,450 Added 12.39%	430,294 $16.9 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $535,987 - $695,018	16,497 Added 4.5%	382,844 $13.8 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $1.45 Million - $1.63 Million	-39,239 Reduced 9.67%	366,347 $15.9 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $167,212 - $183,710	-4,459 Reduced 1.09%	405,586 $17.3 Million
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $280,984 - $320,353	7,304 Added 1.81%	410,045 $17.9 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $331,773 - $402,421	-9,625 Reduced 2.33%	402,741 $17.7 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $128,589 - $137,088	3,899 Added 0.95%	412,366 $15 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $185,333 - $215,012	5,808 Added 1.44%	408,467 $14.5 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $479,509 - $508,775	14,417 Added 3.71%	402,659 $14.6 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $188,604 - $207,768	6,084 Added 1.59%	388,242 $13.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	382,158	382,158 $0

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account